KRAS and pancreatic neoplasm: Berrozpe et al. revealed that 71% of pancreatic cancer cases demonstrated mutations in the KRAS gene, primarily at codon 12, indicative of the pivotal role of these mutations in pancreatic tumorigenesis [123].